Resources
16 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 11/30/2021 (updated 3/26/2024)
Peer providers are viable, evidence based, stand alone or additions to comprehensive teams that approach struggle interventions. Peer providers can be appropriate for any environment that have people with challenges ranging from substance use, gun violence, domestic violence to mental health experiences.
Learning Objectives:
What are the certifications that a peer provider can receive? You will walk away knowing various ways peers can show up in the workplace.
What additional training do peer providers need? Information on what trainings would be helpful for peers to be able to support others well will be provided.
How do we find, support and retain peer providers in the work place? Knowing where to recruit peers, how to keep the workplace well for peer will be knowledge you will leave with.
Presenter: Tanya Kraege
Posted 3/15/2022 (updated 3/27/2024)
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Posted 5/4/2022 (updated 3/27/2024)
Data supporting the positive outcomes associated with peer support integration throughout the substance use disorder continuum of intervention and care has led nationally to systems integrating members of this relatively new workforce into their teams. Among most peer certifying authorities, sustained recovery from substance use disorder is one of the requirements to become a peer. Although substance use recurrence or “relapse” is not common among those in sustained recovery, it does happen. This webinar will introduce suggested considerations when attempting to draft model recurrence policy for peer support employers.
Posted 8/17/2022 (updated 3/27/2024)
This presentation will detail the efforts behind the grant to develop a Recovery Friendly Workplace credential through training, technical assistance, and support that assists businesses in fostering a workplace culture that promotes employee safety, health, and well-being.
Posted 6/8/2023 (updated 3/27/2024)
There are multiple systems that can help individuals to address substance use disorder (SUD). A new report from the Addiction and Public Policy Initiative of the O’Neill Institute for National and Global Health Law at Georgetown Law Center discusses how these multiple systems are often disjointed which creates barriers for those needing to access services for SUD.
Posted 9/4/2020 (updated 3/29/2024)
Like all professions, the addictions treatment field is faced with the challenges of employee substance use and abuse and their impact on retention of quality staff. Because the addictions field employees a disproportionate number of individuals – by recent estimates close to half of the treatment workforce – in recovery, the field faces particular retention challenges. This toolkit provides meaningful and practical guidance to the problem of substance misuse among addictions professionals.
Posted 7/28/2021 (updated 4/2/2024)
Various state and local jurisdictions in the United States are implementing mobile models for treating opioid use disorder (OUD). In August 2020, RTI International spoke with six agencies to learn more about their mobile treatment programs. This article is the first in a three-part series on mobile response programs and provides an in-depth look at two of these programs. We will discuss the remaining programs in two subsequent articles. The goal of this series is to inform jurisdictions considering whether a mobile treatment program would work in their communities and to determine what type of model would fit best.
Posted 7/28/2021 (updated 4/2/2024)
The most effective treatments for opioid use disorder (OUD) are the three prescription medications approved by the U.S. Food and Drug Administration (FDA)—methadone, buprenorphine, and naltrexone—that are proved to increase a patient’s treatment retention and reduce illicit use and the risk of overdose. The only facilities legally able to offer all three medications are opioid treatment programs (OTPs), a critical component of the U.S. substance use treatment system that are regulated by the federal Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA), as well as state agencies, and are certified to administer any FDA-approved medication for the treatment of OUD.
Posted 9/1/2021 (updated 4/2/2024)
Posted 9/1/2021 (updated 4/2/2024)